Appeal result

Eli Lilly and Company (Respondent) v Actavis UK Limited and others (Appellants)

Eli Lilly and Company (Respondent) v Actavis UK Limited and others (Appellants)

7 July 2017

The Supreme Court allows Eli Lilly's appeal and holds that Actavis' products directly infringe Eli Lilly's patent in the United Kingdom, France, Italy and Spain. The Court dismisses Actavis' cross-appeal on the basis that if its products did not directly infringe, they would indirectly infringe to the extent held by the Court of Appeal.

Case details